NCT06167759

Brief Summary

The effect of pain agreements to reduce opioid misuse is an accepted practice in many settings, but it has never been applied to the acute care setting. Pain agreements are considered the standard of care for chronic pain management reliant on opioid prescribing, and they are a mandated component of care in many states. Therefore, the adjunct of safe opioid use agreements into acute pain management offers a logical extension of current practices from chronic pain management. This study will test the use of agreements to improve safe opioid use to prevent misuse and opioid-related harm.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

December 12, 2023

Status Verified

December 1, 2023

Enrollment Period

1.4 years

First QC Date

December 4, 2023

Last Update Submit

December 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient self-reported disposal of prescription opioids

    Patient self-reported disposal of prescription opioids

    25-40 days after surgery

Secondary Outcomes (5)

  • Opioid pills used

    25-40 days after surgery

  • Opioid pills leftover

    25-40 days after surgery

  • Storage method

    25-40 days after surgery

  • Disposal method

    25-40 days after surgery

  • Other pain management strategies

    25-40 days after surgery

Study Arms (2)

Opioid Use Agreement

EXPERIMENTAL

Patients in this group will be administered a safe opioid use agreement by the research coordinator. This agreement is in addition to any routine education and counseling provided by the surgical team.

Other: Opioid Use Agreement

Standard of Care

NO INTERVENTION

Patients in this group will receive standard care which includes safe opioid education from the surgical care team.

Interventions

This was previously developed specifically for surgical patients using a modified Delphi method with a group of experts (including surgeons, nurses, advanced practices providers, quality improvement experts, and patients).

Opioid Use Agreement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (at least 18 years of age), of any gender, who speak English or Spanish, undergoing general surgery procedures with a high likelihood of receiving an opioid prescription (bariatric, inguinal hernia, or ventral hernia), who have their preoperative appointment at UT Physicians Health Center at Memorial Hermann Sugar Land Medical Plaza, Lyndon Baines Johnson, and Bellaire

You may not qualify if:

  • Patients with a known allergy or contra-indication to opioids, pregnancy, signification cognitive impairment, history of opioid misuse/abuse, chronic opioid use, readmission before the follow up appointment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

UT Physicians-MIST Bellaire Clinic

Bellaire, Texas, 77401, United States

Location

Lyndon B. Johnson General Hospital

Houston, Texas, 77026, United States

Location

UT Physicians-MIST Sugar Land Clinic

Sugar Land, Texas, 77478, United States

Location

MeSH Terms

Conditions

Hernia, InguinalHernia, Ventral

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Jonah J Stulberg, MD

    UTHealth

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 4, 2023

First Posted

December 12, 2023

Study Start

December 5, 2022

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

December 12, 2023

Record last verified: 2023-12

Locations